Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC10A1 | Q14973 | 15/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.40 |
| ▸ | FSCN1 | Q16658 | 1/20 | 0.37 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30388015 | 1.00 | SLC10A1 (0.46) | SLC10A1GRM4FSCN1IMPDH2LRRK2 | |
| SCHEMBL21428047 | 1.00 | SLC10A1 (0.46) | SLC10A1GRM4FSCN1IMPDH2LRRK2 | |
| SCHEMBL17838271 | 0.88 | SLC10A1 (0.44) | SLC10A1GRM4FSCN1 | |
| SCHEMBL17838309 | 0.87 | SLC10A1 (0.43) | SLC10A1GRM4FSCN1 | |
| SCHEMBL16421467 | 0.87 | SLC10A1 (0.47) | SLC10A1GRM4FSCN1 | |
| SCHEMBL21408378 | 0.85 | GRM4 (0.43) | SLC10A1GRM4FSCN1IMPDH2LRRK2 | |
| SCHEMBL28898148 | 0.84 | GRM4 (0.39) | SLC10A1GRM4FSCN1IMPDH2LRRK2 | |
| SCHEMBL21408544 | 0.84 | SLC10A1 (0.49) | SLC10A1GRM4LRRK2 | |
| SCHEMBL21428046 | 0.84 | SLC10A1 (0.49) | SLC10A1GRM4LRRK2 | |
| SCHEMBL31659293 | 0.84 | SLC10A1 (0.49) | SLC10A1GRM4LRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115974753-A | N-containing heterocyclic five-membered ring compound and application | 正大天晴药业集团股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-111868026-A | Capsid protein assembly inhibitor containing N-heterocyclic five-membered ring, pharmaceutical composition and application thereof | 正大天晴药业集团股份有限公司 | 2020-10-30 | — | — | CN | disclosed |